Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Carelon Research

Status: Completed

Conditions: Down Syndrome; Congenital Heart Disease

Treatments: Other: Stanford Binet Intelligence Scales, Fifth Edition; Other: Social Communication Questionnaire, Current Form; Other: Peabody Picture Vocabulary Test, Fifth Edition; Other: Vineland Adaptive Behavior Scales Third Edition; Other: Aberrant Behavior Checklist; Other: Expressive Vocabulary Test, Third Edition; Other: Leiter International Performance Scale, Third Edition; Other: Repetitive Behavior Scale, Revised

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05312177

CHILD-DS

3U24HL135691-03S1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The study objective is to compare neurodevelopmental (ND) and behavioral outcomes between children with Down syndrome (DS) who had complete atrioventricular septal defect (CAVSD) repair and children from the same clinical sites with DS without major congenital heart disease (CHD) requiring previous or planned CHD surgery.

Full description

We are conducting a multicenter cohort study, ancillary to the Pediatric Heart Network (PHN) Residual Lesion Score (RLS) study, to investigate determinants of ND and behavioral outcomes in children with DS, focusing on the role of CHD surgery. We are including children with DS who had CAVSD repair, as this group comprises 91% of all children with DS in the RLS Study, with similar underlying congenital cardiac defect and surgical repair complexity, allowing our children with DS and CHD to be a homogeneous group. Moreover, one in five individuals with DS is born with an AVSD, a 2000 times higher incidence than in those with normal chromosomes. In addition to recruiting children with DS who had CAVSD repair, we will recruit similarly-aged children with DS who do not have documented major CHD (i.e., CHD requiring previous or planned CHD surgery) to come into the same PHN site for a single study visit consisting of detailed phenotyping by completion of a Health & Developmental History Intake form, ND and behavioral assessments, and optional collection and storage of saliva specimens in the PHN Biorepository. By building our sample from RLS Study participants and recruiting additional children who had infant CAVSD repair and meet study eligibility criteria, as well as a comparison group from the same PHN sites, we are leveraging rich prospective data in a group of DS children with CAVSD repair from a nationally representative sample, and the expertise of the PHN and Boston Children's Hospital (BCH).

Enrollment: 273 patients

Sex: All

Ages: 60 to 155 months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Down Syndrome CAVSD Repair Group:

• Trisomy 21
• Male or Female, ages 5 years through 12 years
• Had CAVSD repair within the first year of life
• Parent or guardian and patient willing to comply with protocol and complete all study assessments; parent or guardian willing to provide written informed consent
• Child able to speak and understand English

Down Syndrome Comparison Group

• Trisomy 21
• Male or Female, age 5 years through 12 years
• No major CHD, defined as CHD requiring previous or planned CHD surgery
• Parent or guardian and patient willing to comply with protocol and complete all study assessments; parent or guardian willing to provide written informed consent
• Child able to speak and understand English

Exclusion criteria

Both Groups

• Mosaic DS

Down Syndrome CAVSD Repair Group only - Did not have CAVSD repair in the first year of life

Down Syndrome Comparison Group only

• Major CHD requiring previous or planned CHD surgery - i.e., CHD surgery occurring (a) in the period between birth and time of recruitment into the CHILD-DS Study, or (b) planned for a future date.

Trial design

273 participants in 2 patient groups

DS with CAVSD Repair

Description:

Children ages 5 through 12 years with Down syndrome who had Complete atrioventricular septal defect (CAVSD) repair in the first year of life and their parent(s) will be administered the Stanford-Binet Intelligence Scales, Fifth Edition (SB-5), Peabody Picture Vocabulary Test, Fifth Edition (PPVT-5), Expressive Vocabulary Test, Third Edition (EVT-3), Leiter International Performance Scale, Third Edition (Leiter-3), Vineland-3 Q-global Comprehensive Report (Vineland-3) ,Social Communication Questionnaire, Current version (SCQ), Aberrant Behavior Checklist, Second Edition, (ABC-2) and Repetitive Behavior Scale, Revised (RBS-R)

Treatment:

Other: Repetitive Behavior Scale, Revised

Other: Leiter International Performance Scale, Third Edition

Other: Aberrant Behavior Checklist

Other: Expressive Vocabulary Test, Third Edition

Other: Vineland Adaptive Behavior Scales Third Edition

Other: Peabody Picture Vocabulary Test, Fifth Edition

Other: Social Communication Questionnaire, Current Form

Other: Stanford Binet Intelligence Scales, Fifth Edition

DS without major CHD

Description:

Children ages 5 through 12 years with Down syndrome without major Congenital Heart Disease(CHD) and their parent(s) will be administered the Stanford-Binet Intelligence Scales, Fifth Edition (SB-5), Peabody Picture Vocabulary Test, Fifth Edition (PPVT-5), Expressive Vocabulary Test, Third Edition (EVT-3), Leiter International Performance Scale, Third Edition (Leiter-3), Vineland-3 Q-global Comprehensive Report (Vineland-3) ,Social Communication Questionnaire, Current version (SCQ), Aberrant Behavior Checklist, Second Edition, (ABC-2) and Repetitive Behavior Scale, Revised (RBS-R)

Treatment:

Other: Repetitive Behavior Scale, Revised

Other: Leiter International Performance Scale, Third Edition

Other: Aberrant Behavior Checklist

Other: Expressive Vocabulary Test, Third Edition

Other: Vineland Adaptive Behavior Scales Third Edition

Other: Peabody Picture Vocabulary Test, Fifth Edition

Other: Social Communication Questionnaire, Current Form

Other: Stanford Binet Intelligence Scales, Fifth Edition